title: Author reply: To PMID 23582989.
authors.affiliation: Bascom Palmer Eye Institute, Miami, Florida.
authors.forename: David T
authors.initials: DT
authors.lastname: Tse
authors.affiliation: Bascom Palmer Eye Institute, Miami, Florida.
authors.forename: Andrea L
authors.initials: AL
authors.lastname: Kossler
authors.affiliation: Bascom Palmer Eye Institute, Miami, Florida.
authors.forename: William J
authors.initials: WJ
authors.lastname: Feuer
authors.affiliation: Bascom Palmer Eye Institute, Miami, Florida.
authors.forename: Pasquale W
authors.initials: PW
authors.lastname: Benedetto
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003528:Carcinoma, Adenoid Cystic / Q000188:drug therapy*; D002945:Cisplatin / Q000627:therapeutic use*; D004317:Doxorubicin / Q000627:therapeutic use*; D005134:Eye Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007766:Lacrimal Apparatus Diseases / Q000188:drug therapy*; D008297:Male
chemical_list: D004317:Doxorubicin; D002945:Cisplatin